Mechanismus der UCP-Aktivierung durch reaktive Aldehyde
Kurzbezeichnung
Mechanismus der UCP-Aktivierung
Projektleitung an der Vetmeduni
Einrichtung Vetmeduni
Geldgeber
Art der Forschung
Grundlagenforschung
Laufzeit
01.11.2012
-
30.04.2017
Projektkategorie
Einzelprojekt
Abstract
Free radicals (ROS) have been implicated in aetiology of many pathological states such as metabolic,
cardiovascular and inflammatory failures. Understanding ROS action mechanisms is crucial for the
development of potent therapeutic strategies in the treatment of these diseases. Uncoupling proteins (UCP)
are thought to be involved in ROS regulation by transporting protons through the inner mitochondrial
membrane, thereby diminishing transmembrane potential. On the other side, they are proposed to be
regulated by ROS. In our previous project (Po-524/3, German Research Foundation) we have shown, that
reactive aldehyde, 4-hydroxy-2-nonenal (HNE), leads to the increase of UCP1 activity only if fatty acids
(FA) are present. The main goal of the present project is the evaluation of mechanisms leading to FAmediated
uncoupling protein activation in the presence of HNE. We will test two main hypotheses
concerning the main mechanism of the proton transport mediated by HNE: (i) reactive aldehyde
influences lipid membrane parameters, leading to the facilitation of fatty acid transport (e.g. membrane
fluidity, dipole or surface membrane potential) or/and (ii) HNE binding to the protein leads to the transient
proton channel formation due to conformational change of protein. We use two different experimental
systems, bilayer lipid membranes reconstituted with uncoupling proteins and primary neuronal cell
cultures, which are supposed to complement each other. We will investigate the influence of other
biologically important reactive aldehydes such as malondialdehyde, 4-oxo-2-nonenal and 4-oxo-2-hexenal
on the protein transport function and evaluate possible mechanisms. From the results obtained we expect
to gain mechanistic insight into the controversially discussed regulation of UCP1 and UCP2 by HNE and
other reactive aldehydes, which is important for drug design.